Cedara (NASDAQ:CDSW)
Historical Stock Chart
From Jun 2019 to Jun 2024
![Click Here for more Cedara Charts. Click Here for more Cedara Charts.](/p.php?pid=staticchart&s=N%5ECDSW&p=8&t=15)
Cedara OrthoWorks Care Manager(TM) Named Product Innovation of
the Year by Frost & Sullivan
TORONTO, May 26 /PRNewswire-FirstCall/ -- CEDARA SOFTWARE CORP.
(TSX:CDE/NASDAQ:CDSW), a leading independent provider of medical imaging
technologies for the global healthcare market, has been awarded Product
Innovation of the Year by Frost & Sullivan LLC for its Cedara OrthoWorks Care
Manager.
Cedara OrthoWorks Care Manager is a powerful clinical data management system
that organizes clinical information, allowing data analysis and manipulation.
Useful for multi-centric studies, orthopaedic implant tracking, insurance claim
evaluations and systematic patient clinical follow-up, Care Manager has
widespread applications throughout the healthcare industry.
In reference to the award, Frost & Sullivan Analyst Sachin Thukral said
"Orthopedic surgeons usually maintain manual records of surgeries with separate
records for care and recovery. This 'hard copy approach' makes it time
consuming for surgeons and technicians to perform statistical analysis and
visualize trends. In order to simplify and accelerate the process, Cedara
Software has provided the healthcare community with Orthoworks Care Manager.
This revolutionary tool facilitates efficient data mining and statistical
analysis and ultimately helps provide real-time feedback for patient treatment
strategies."
OrthoWorks Care Manager was developed in association with one of Cedara's
technology partners, SurgiView, a Paris-based company known for developing
transversal tools based on software technologies dedicated to clinical data
management for different surgical & medical specialties.
OrthoWorks Care Manager employs a proprietary technology that captures relevant
clinical parameters during diagnosis, therapy and post-therapy follow-up, which
transfers the data into a structured query language (SQL) database. It is
equipped with powerful, yet intuitive data-mining tools to perform outcome
analysis that in turn can be analyzed by statistical packages. OrthoWorks Care
Manager promotes data sharing between various centers via a secure e-mail
system, thereby allowing the exchange of information, and/or centralization of
data in case of multi-center studies. Furthermore, OrthoWorks Care Manager,
which represents a confluence of imaging capabilities and data mining
techniques, saves surgeons valuable time and vastly accelerates data
compilation. OrthoWorks Care Manager features an exclusive repository where a
surgeon can access key orthopedic and image data.
As part of the OrthoWorks suite of applications, image-generated data such as
hard tissue measurements and volumes can be automatically populated into Care
Manager, eliminating potential data entry errors and expediting workflow. When
used in conjunction with Cedara OrthoWorks Spine Analyzer(TM), spinal
measurements can be quickly tracked in this fashion to better understand the
benefits of a surgery, or to analyze tendency of outcomes in a population
during a study. Other applications could include automated tracking of tumour
dimensions and cartilage thickness through Care Manager. The Cedara OrthoWorks
product line includes applications that allow:
- Multi modality viewing capabilities from one workstation
- Customized scripts that mimic orthopaedic planning methodologies
- Standalone or remote Web-Based orthopaedic surgical planning
- Real-time 3D Reconstruction to identify structures and/or remove
obscuring tissue
Cedara OrthoWorks Care Manager was evaluated by Frost & Sullivan on a variety
of different criteria for the Product Innovation of the Year Award, including
product significance, competitive advantage, innovation and acceptance in a
given marketplace. Product launches and new products in development from
different companies were compared and evaluated based on their degree of
innovation and customer satisfaction. In selecting a recipient, the analyst
team tracked new product launches, R&D spending, products in development, as
well as new product features and modifications.
Marwan Sati, Director of Medical Applications at Cedara Software said, "It is
an honour to receive Frost & Sullivan's Product Innovation of the Year award.
Care Manager is a powerful application that was developed by surgeons for
surgeons, which has allowed us to solve many of the problems present in
clinical data management today. For implant manufacturers, Care Manager can
assist in the tracking and analyzing of implant usage, pain thresholds,
recovery rates, complications, mobility, mortality and a host of other clinical
outcome statistics. Care Manager will play a key role in improving patient
care."
About Cedara Software Corp.
Cedara Software Corp. is a leading independent provider of medical imaging
technologies. Cedara's software is deployed in hospitals and clinics worldwide
and is licensed by many of the world's leading medical device and healthcare
information technology companies. Approximately 28,000 medical imaging systems
and 6,400 Picture Archiving and Communications System (PACS) workstations have
been licensed to date. Cedara recently acquired eMed Technologies Corporation,
widely known as a provider of innovative PACS and teleradiology solutions that
have been installed in over 2,000 hospitals and imaging centres. Cedara is
unique in that it has technologies and expertise that span all the major
digital imaging modalities including computed tomography (CT), magnetic
resonance imaging (MRI), digital X-ray, mammography, ultrasound,
echo-cardiology, angiography, nuclear medicine, positron emission tomography
(PET) and fluoroscopy. Furthermore, the Company's medical imaging offerings are
used in all aspects of clinical workflow including the capture of a patient's
digital image; the archiving, communication and manipulation of digital images;
sophisticated clinical applications to analyze digital images; and even the use
of imaging in minimally-invasive surgery. On January 18, 2005, Cedara announced
that it had signed a definitive agreement to merge with Merge Technologies
Incorporated (NASDAQ:MRGE), d.b.a. Merge eFilm, in an all-stock transaction.
The merger is subject to court approval and is expected to close on or about
June 1, 2005.
Certain statements contained in this news release are forward-looking within
the meaning of securities laws and are based on current expectations that are
subject to a number of assumptions, uncertainties and risks, and the actual
results may differ materially from what is currently expected. In particular,
statements relating to the healthcare imaging software market and market share,
relating to the Company's expectations concerning its licensed software
products, relating to the Company's expectations as to revenues, costs and cash
flows, relating to the acquisition of eMed and relating to the proposed merger
with Merge eFilm are forward-looking statements. The assumptions, uncertainties
and risks upon which these forward looking statements are based include, but
are not limited to: dependence on key personnel of the Company, dependence on
major customers and individual contracts, fluctuations in quarterly financial
results, competitive pressures (including price competition), rapid
technological change, exchange rate fluctuations, risks associated with
international operations, dependence on intellectual property rights,
regulatory clearances and approvals for new products, risks relating to product
defects and product liability, adverse consequences of financial leverage,
ability to service debt, continued acceptance of the Company's products,
regulatory changes to the health care industry, seasonality, economic and
political conditions, risks relating to the acquisition of eMed and risks
relating to the proposed merger with Merge eFilm including risks associated
with obtaining regulatory and shareholder approvals without unexpected delays
or conditions, timely implementation and execution of merger integration plans,
retention of customers and the Company's original employees, successfully
leveraging Merge eFilm's and the Company's comprehensive product offering to
the combined customer base and sustaining continued growth at rates
approximating recent levels. Further information about these risks and
uncertainties can be found in the continuous disclosure documents filed from
time to time by Cedara with the securities regulatory authorities, which
documents are available at http://www.sedar.com/.
For more information, visit the Cedara website at http://www.cedara.com/.
All trademarks appearing in this release are the property of Cedara
Software Corp.
DATASOURCE: Cedara Software Corp.
CONTACT: Jacques Cornet, VP of Marketing & Operations, Cedara Software
Corp., (905) 672-2100 ext. 2564, ;
To request a free copy of this organization's annual report, please go to
http://www.newswire.ca/ and click on reports@cnw.